About Cogentix Medical (NASDAQ:CGNT)
Cogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: N/A
- Symbol: NASDAQ:CGNT
- CUSIP: N/A
- Web: www.cogentixmedical.com
- Market Cap: $181.53 million
- Outstanding Shares: 60,914,000
- 50 Day Moving Avg: $2.74
- 200 Day Moving Avg: $2.06
- 52 Week Range: $1.37 - $3.26
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -72.25
- P/E Growth: -9.93
- Annual Revenue: $53.65 million
- Price / Sales: 3.28
- Book Value: $1.04 per share
- Price / Book: 2.78
- EBITDA: $3.2 million
- Net Margins: -35.88%
- Return on Equity: -13.83%
- Return on Assets: -10.53%
- Current Ratio: 5.55%
- Quick Ratio: 4.55%
- Average Volume: 70,806 shs.
- Beta: 0.72
- Short Ratio: 2.03
Frequently Asked Questions for Cogentix Medical (NASDAQ:CGNT)
What is Cogentix Medical's stock symbol?
Cogentix Medical trades on the NASDAQ under the ticker symbol "CGNT."
How were Cogentix Medical's earnings last quarter?
Cogentix Medical, Inc. (NASDAQ:CGNT) issued its quarterly earnings results on Tuesday, August, 1st. The company reported $0.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.01) by $0.02. The firm had revenue of $14.06 million for the quarter, compared to analyst estimates of $13.90 million. Cogentix Medical had a negative return on equity of 13.83% and a negative net margin of 35.88%. View Cogentix Medical's Earnings History.
When will Cogentix Medical make its next earnings announcement?
Where is Cogentix Medical's stock going? Where will Cogentix Medical's stock price be in 2017?
1 analysts have issued 1 year price objectives for Cogentix Medical's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate Cogentix Medical's share price to reach $5.00 in the next twelve months. View Analyst Ratings for Cogentix Medical.
Who are some of Cogentix Medical's key competitors?
Some companies that are related to Cogentix Medical include Accuray Incorporated (ARAY), Corindus Vascular Robotics (CVRS), Cytosorbents Corporation (CTSO), Harvard Bioscience (HBIO), Neovasc (NVCN), IRIDEX Corporation (IRIX), Viveve Medical (VIVE), Edap Tms S.A. (EDAP), Presbia PLC (LENS), Fulgent Genetic (FLGT), Electromed (ELMD), Biolase (BIOL), Invivo Therapeutics Holdings Corp (NVIV), Digirad Corporation (DRAD), Luna Innovations Incorporated (LUNA), EnteroMedics (ETRM), Advanced Oncotherapy PLC (AVO) and Xtant Medical Holdings (XTNT).
Who are Cogentix Medical's key executives?
Cogentix Medical's management team includes the folowing people:
- Uri Geiger, Chairman of the Board
- Darin Hammers, President, Chief Executive Officer, Director
- Brett A. Reynolds, Chief Financial Officer, Senior Vice President, Principal Financial Officer, Principal Accounting Officer, Secretary
- Kenneth H. Paulus, Director
- Cheryl Pegus M.D., Director
- Lewis C. Pell, Director
- Kevin H. Roche, Director
- Nachum Shamir, Director
How do I buy Cogentix Medical stock?
Shares of Cogentix Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cogentix Medical's stock price today?
MarketBeat Community Rating for Cogentix Medical (NASDAQ CGNT)MarketBeat's community ratings are surveys of what our community members think about Cogentix Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Cogentix Medical stock can currently be purchased for approximately $2.89.
Consensus Ratings for Cogentix Medical (NASDAQ:CGNT) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$5.00 (73.01% upside)|Consensus Price Target History for Cogentix Medical (NASDAQ:CGNT)
Analysts' Ratings History for Cogentix Medical (NASDAQ:CGNT)
(Data available from 10/21/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/6/2017||JMP Securities||Initiated Coverage||Mkt Outperform -> Outperform||$5.00||N/A|
|9/7/2016||Roth Capital||Upgrade||Neutral -> Buy||N/A|
Earnings History for Cogentix Medical (NASDAQ:CGNT)Earnings History by Quarter for Cogentix Medical (NASDAQ CGNT)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/1/2017||Q2 2017||($0.01)||$0.01||$13.90 million||$14.06 million||View||Listen|
|5/2/2017||Q1 2017||($0.01)||($0.02)||$13.14 million||$12.95 million||View||Listen|
|3/9/2017||Q4 2016||($0.14)||$13.81 million||$13.23 million||View||Listen|
|11/3/2015||Q216||($0.07)||($0.06)||$11.45 million||$11.80 million||View||N/A|
|8/10/2015||Q116||($0.10)||($0.07)||$11.34 million||$11.20 million||View||Listen|
|5/14/2015||Q415||($0.06)||($0.15)||$49.10 million||$7.00 million||View||Listen|
|2/3/2014||Q3 14||($0.03)||$4.00 million||$4.50 million||View||N/A|
|8/12/2013||Q1 2014||($0.05)||$34.00 million||$3.70 million||View||N/A|
|11/5/2012||Q213||($0.06)||($0.07)||$3.85 million||$3.70 million||View||N/A|
Earnings Estimates for Cogentix Medical (NASDAQ:CGNT)
2017 EPS Consensus Estimate: ($0.02)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Cogentix Medical (NASDAQ:CGNT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Cogentix Medical (NASDAQ:CGNT)
Insider Ownership Percentage: 62.70%Insider Trades by Quarter for Cogentix Medical (NASDAQ:CGNT)
Institutional Ownership Percentage: 12.67%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/18/2016||Kenneth A Samet||Director||Buy||25,000||$2.47||$61,750.00|| |
|6/10/2016||Lewis C Pell||Director||Buy||13,291||$0.95||$12,626.45|| |
|6/1/2016||Lewis C Pell||Director||Buy||894||$0.75||$670.50|| |
|5/31/2016||Lewis C Pell||Director||Buy||500,000||$0.79||$395,000.00|| |
|5/21/2015||Kevin H Roche||Director||Buy||10,000||$1.68||$16,800.00|| |
|5/19/2015||Kevin H Roche||Director||Buy||10,000||$1.60||$16,000.00|| |
|2/20/2015||Lewis C Pell||Director||Buy||20,000||$0.51||$10,200.00|| |
|2/19/2015||Lewis C Pell||Director||Buy||10,000||$0.48||$4,800.00|| |
|2/18/2015||Lewis C Pell||Director||Buy||30,000||$0.45||$13,500.00|| |
|2/13/2015||Lewis C Pell||Director||Buy||20,000||$0.47||$9,400.00|| |
|2/11/2015||Lewis C Pell||Director||Buy||35,000||$0.46||$16,100.00|| |
|12/23/2014||Lewis C Pell||Director||Buy||80,000||$0.85||$68,000.00|| |
|12/22/2014||Lewis C Pell||Director||Buy||40,000||$0.86||$34,400.00|| |
|9/23/2014||Lewis C Pell||Director||Buy||5,000||$0.99||$4,950.00|| |
|9/19/2014||Lewis C Pell||Director||Buy||3,900||$1.00||$3,900.00|| |
|9/17/2014||Lewis C Pell||Director||Buy||5,000||$1.02||$5,100.00|| |
|9/16/2014||Lewis C Pell||Director||Buy||5,000||$1.07||$5,350.00|| |
|9/12/2014||Lewis C Pell||Director||Buy||23,300||$1.04||$24,232.00|| |
|9/8/2014||Lewis C Pell||Director||Buy||30,000||$1.04||$31,200.00|| |
|9/3/2014||Lewis C Pell||Director||Buy||30,000||$0.98||$29,400.00|| |
|8/27/2014||Lewis C Pell||Director||Buy||10,000||$0.92||$9,200.00|| |
|8/26/2014||Lewis C Pell||Director||Buy||30,000||$0.93||$27,900.00|| |
|8/19/2014||Lewis C Pell||Director||Buy||22,900||$0.98||$22,442.00|| |
|8/13/2014||Lewis C Pell||Director||Buy||43,420||$0.91||$39,512.20|| |
|8/8/2014||Lewis C Pell||Director||Buy||27,500||$0.95||$26,125.00|| |
|6/6/2014||Lewis C Pell||Director||Buy||10,000||$1.13||$11,300.00|| |
|5/21/2014||Lewis C Pell||Director||Buy||5,000||$1.09||$5,450.00|| |
|5/16/2014||Lewis C Pell||Director||Buy||14,197||$1.02||$14,480.94|| |
|11/18/2013||Lewis C Pell||Director||Buy||6,296||$0.91||$5,729.36|| |
|11/15/2013||Lewis C Pell||Director||Buy||20,000||$0.90||$18,000.00|| |
|9/18/2013||Lewis C Pell||Director||Buy||16,000||$0.91||$14,560.00|| |
|9/13/2013||Lewis C Pell||Director||Buy||5,000||$0.92||$4,600.00|| |
|9/10/2013||Lewis C Pell||Director||Buy||5,000||$0.92||$4,600.00|| |
|9/9/2013||Lewis C Pell||Director||Buy||4,564||$0.95||$4,335.80|| |
|9/6/2013||Lewis C Pell||Director||Buy||5,000||$0.97||$4,850.00|| |
|9/3/2013||Lewis C Pell||Director||Buy||11,432||$0.97||$11,089.04|| |
|8/29/2013||Lewis C Pell||Director||Buy||1,100||$0.98||$1,078.00|| |
|8/27/2013||Lewis C Pell||Director||Buy||11,596||$0.97||$11,248.12|| |
|8/26/2013||Lewis C Pell||Director||Buy||14,965||$0.97||$14,516.05|| |
|8/19/2013||Lewis C Pell||Director||Buy||25,025||$0.94||$23,523.50|| |
|8/15/2013||Lewis C Pell||Director||Buy||15,000||$0.92||$13,800.00|| |
|6/28/2013||Lewis C Pell||Director||Buy||28,400||$1.00||$28,400.00|| |
|6/27/2013||Lewis C Pell||Director||Buy||45,048||$0.99||$44,597.52|| |
|3/15/2013||Lewis C Pell||Director||Buy||30,000||$1.14||$34,200.00|| |
|3/12/2013||Lewis C Pell||Director||Buy||45,000||$1.10||$49,500.00|| |
|3/7/2013||Lewis C Pell||Director||Buy||60,000||$1.09||$65,400.00|| |
|3/4/2013||Lewis C Pell||Director||Buy||20,000||$1.06||$21,200.00|| |
|2/26/2013||Lewis C Pell||Director||Buy||66,266||$1.01||$66,928.66|| |
|2/21/2013||Lewis C Pell||Director||Buy||25,000||$0.99||$24,750.00|| |
|2/19/2013||Lewis C Pell||Director||Buy||5,000||$0.99||$4,950.00|| |
|2/7/2013||Lewis C Pell||Director||Buy||9,000||$0.99||$8,910.00|| |
|2/5/2013||Lewis C Pell||Director||Buy||25,000||$1.01||$25,250.00|| |
|2/1/2013||Lewis C Pell||Director||Buy||10,000||$1.09||$10,900.00|| |
|12/27/2012||Lewis C Pell||Director||Buy||10,000||$1.07||$10,700.00|| |
|12/17/2012||Lewis C Pell||Director||Buy||21,600||$1.10||$23,760.00|| |
|12/13/2012||Lewis C Pell||Director||Buy||18,961||$1.10||$20,857.10|| |
|12/10/2012||Lewis C Pell||Director||Buy||6,656||$1.10||$7,321.60|| |
|12/3/2012||Lewis C Pell||Director||Buy||8,360||$1.10||$9,196.00|| |
|11/30/2012||Lewis C Pell||Director||Buy||45,748||$1.10||$50,322.80|| |
|11/27/2012||Lewis C Pell||Director||Buy||3,593||$1.10||$3,952.30|| |
|11/23/2012||Lewis C Pell||Director||Buy||39,357||$1.09||$42,899.13|| |
|11/19/2012||Lewis C Pell||Director||Buy||57,050||$1.08||$61,614.00|| |
|11/14/2012||Lewis C Pell||Director||Buy||100,000||$1.15||$115,000.00|| |
|11/12/2012||Lewis C Pell||Director||Buy||24,852||$1.17||$29,076.84|| |
|9/6/2012||Lewis C Pell||Director||Buy||10,000||$1.37||$13,700.00|| |
Headline Trends for Cogentix Medical (NASDAQ:CGNT)
Latest Headlines for Cogentix Medical (NASDAQ:CGNT)
Loading headlines, please wait.
Cogentix Medical (CGNT) Chart for Saturday, October, 21, 2017